James George Chopas - 14 Sep 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
VP/Chief Accounting Officer
Signature
/s/ David Watson, attorney-in-fact for James Chopas
Issuer symbol
APLS
Transactions as of
14 Sep 2023
Net transactions value
$0
Form type
4
Filing time
18 Sep 2023, 16:20:20 UTC
Previous filing
01 Sep 2023
Next filing
24 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +2,500 +8.2% $0.000000 32,812 14 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a Restricted Stock Unit award granted 09/14/23 that vest 25% every 6 months from grant date over a two year period subject to continued service.